Literature DB >> 6698161

Sleep states attenuate the pressor response to central amygdala stimulation.

R C Frysinger, J D Marks, R B Trelease, V L Schechtman, R M Harper.   

Abstract

We examined the cardiovascular response to electrical stimulation of the region of the central nucleus of the amygdala during sleep and waking states in the intact cat. Stimulation for 0.5 s produced a profound pressor response in the awake animal. This response was attenuated by quiet sleep and greatly attenuated during REM sleep. The attenuation was present even when the animal aroused from the sleep state in which the stimulus was delivered. The degree of sinus arrhythmia during the bradycardia associated with the hypertensive phase was greater during waking than during quiet sleep. We speculate that REM sleep entails a "functional dissociation" between forebrain and brain stem systems involved in cardiovascular regulation.

Entities:  

Mesh:

Year:  1984        PMID: 6698161     DOI: 10.1016/0014-4886(84)90127-4

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  4 in total

1.  Bidirectional cardiovascular responses evoked by microstimulation of the amygdala in rats.

Authors:  Ko Yamanaka; Miwa Takagishi; Jimmy Kim; Sabine S Gouraud; Hidefumi Waki
Journal:  J Physiol Sci       Date:  2017-01-23       Impact factor: 2.781

2.  Neuronal degeneration in canine narcolepsy.

Authors:  J M Siegel; R Nienhuis; S Gulyani; S Ouyang; M F Wu; E Mignot; R C Switzer; G McMurry; M Cornford
Journal:  J Neurosci       Date:  1999-01-01       Impact factor: 6.167

3.  Alterations in blood pressure and REM sleep after pontine carbachol microinfusion.

Authors:  P J Shiromani; J M Siegel; K S Tomaszewski; D J McGinty
Journal:  Exp Neurol       Date:  1986-02       Impact factor: 5.620

4.  Electrocardiographic changes in patients with refractory epilepsy.

Authors:  Mohammad Zare; Mehri Salari; Marzieh Tajmirriahi; Mohammad Saadatnia; Rasul Norouzi
Journal:  J Res Med Sci       Date:  2013-03       Impact factor: 1.852

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.